{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:24:21Z","timestamp":1783517061402,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100030680","name":"Fu Jen Catholic University Hospital","doi-asserted-by":"publisher","award":["PL-202208034-V"],"award-info":[{"award-number":["PL-202208034-V"]}],"id":[{"id":"10.13039\/100030680","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Development Center for Medical Devices, National Taiwan University","award":["115KKZA3T1"],"award-info":[{"award-number":["115KKZA3T1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52247-7","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:35:43Z","timestamp":1778250943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intratumoral microbial networks as biomarkers for second primary oral cancer risk in esophageal squamous cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Wei-Ni","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jian","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Hua","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Kuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jen","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Y.","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mong-Hsun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"52247_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00535-022-01870-y","volume":"57","author":"S Mitani","year":"2022","unstructured":"Mitani, S. et al. Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502. J. Gastroenterol. 57, 455\u2013463. https:\/\/doi.org\/10.1007\/s00535-022-01870-y (2022).","journal-title":"J. Gastroenterol."},{"key":"52247_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2006.01621.x","volume":"36","author":"IC Wu","year":"2006","unstructured":"Wu, I. C. et al. Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. Eur. J. Clin. Invest. 36, 236\u2013241 (2006).","journal-title":"Eur. J. Clin. Invest."},{"key":"52247_CR3","doi-asserted-by":"publisher","first-page":"e72097","DOI":"10.1371\/journal.pone.0072097","volume":"8","author":"SH Hung","year":"2013","unstructured":"Hung, S. H., Tsai, M. C., Liu, T. C., Lin, H. C. & Chung, S. D. Routine endoscopy for esophageal cancer is suggestive for patients with oral, oropharyngeal and hypopharyngeal cancer. PLoS One. 8, e72097. https:\/\/doi.org\/10.1371\/journal.pone.0072097 (2013).","journal-title":"PLoS One"},{"key":"52247_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3904\/kjim.2014.182","volume":"31","author":"JS Lee","year":"2016","unstructured":"Lee, J. S. et al. Synchronous second primary cancers in patients with squamous esophageal cancer: Clinical features and survival outcome. Korean J. Intern. Med. 31, 253\u2013259. https:\/\/doi.org\/10.3904\/kjim.2014.182 (2016).","journal-title":"Korean J. Intern. Med."},{"key":"52247_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/lio2.179","volume":"3","author":"T Matsui","year":"2018","unstructured":"Matsui, T. et al. Detection of second primary malignancies of the esophagus and hypophraynx in oral squamous cell carcinoma patients. Laryngoscope Investig Otolaryngol. 3, 263\u2013267. https:\/\/doi.org\/10.1002\/lio2.179 (2018).","journal-title":"Laryngoscope Investig Otolaryngol."},{"key":"52247_CR6","doi-asserted-by":"crossref","unstructured":"Qi, X., Su, X., Wang, C., Yao, Q. & Fan, Y. Risk of second cancer in esophageal squamous cell carcinoma and adenocarcinoma survivors: A population-based analysis in SEER dataset. Transl. Gastroenterol. Hepatol. 8 (2023).","DOI":"10.21037\/tgh-23-29"},{"key":"52247_CR7","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1002\/cncr.32403","volume":"125","author":"D Shao","year":"2019","unstructured":"Shao, D. et al. Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China. Cancer 125, 3993\u20134002. https:\/\/doi.org\/10.1002\/cncr.32403 (2019).","journal-title":"Cancer"},{"key":"52247_CR8","doi-asserted-by":"crossref","unstructured":"Tustumi, F. et al. Prognostic factors and survival analysis in esophageal carcinoma. Arq. Bras. Cir. Dig. 29, 138\u2013141 (2016).","DOI":"10.1590\/0102-6720201600030003"},{"key":"52247_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000517736","volume":"40","author":"R Bernard","year":"2022","unstructured":"Bernard, R., Fazili, I., Rajagopala, S. V., Das, S. R. & Hiremath, G. Association between oral microbiome and esophageal diseases: A state-of-the-art review. Dig. Dis. 40, 345\u2013354. https:\/\/doi.org\/10.1159\/000517736 (2022).","journal-title":"Dig. Dis."},{"key":"52247_CR10","doi-asserted-by":"crossref","unstructured":"Chai, Y. et al. Microbiota regulates pancreatic cancer carcinogenesis through altered immune response. Microorganisms 11, 1240 (2023).","DOI":"10.3390\/microorganisms11051240"},{"key":"52247_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4248\/IJOS11075","volume":"3","author":"J Katz","year":"2011","unstructured":"Katz, J., Onate, M. D., Pauley, K. M., Bhattacharyya, I. & Cha, S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int. J. Oral Sci. 3, 209\u2013215. https:\/\/doi.org\/10.4248\/IJOS11075 (2011).","journal-title":"Int. J. Oral Sci."},{"key":"52247_CR12","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1002\/cam4.3206","volume":"9","author":"J Sun","year":"2020","unstructured":"Sun, J. et al. Role of the oral microbiota in cancer evolution and progression. Cancer Med. 9, 6306\u20136321. https:\/\/doi.org\/10.1002\/cam4.3206 (2020).","journal-title":"Cancer Med."},{"key":"52247_CR13","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1158\/1055-9965.EPI-19-0008","volume":"28","author":"EJ Snider","year":"2019","unstructured":"Snider, E. J. et al. Alterations to the esophageal microbiome associated with progression from Barrett\u2019s esophagus to esophageal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 28, 1687\u20131693. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0008 (2019).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"52247_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857. https:\/\/doi.org\/10.1038\/s41587-019-0209-9 (2019).","journal-title":"Nat. Biotechnol."},{"key":"52247_CR15","doi-asserted-by":"publisher","unstructured":"Liu, K. et al. Oral microbiota of children Is conserved across Han, Tibetan and Hui groups and Is correlated with diet and gut microbiota. Microorganisms 9. https:\/\/doi.org\/10.3390\/microorganisms9051030 (2021).","DOI":"10.3390\/microorganisms9051030"},{"key":"52247_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2011","unstructured":"Smoot, M. E., Ono, K., Ruscheinski, J., Wang, P. L. & Ideker, T. Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics 27, 431\u2013432. https:\/\/doi.org\/10.1093\/bioinformatics\/btq675 (2011).","journal-title":"Bioinformatics"},{"key":"52247_CR17","doi-asserted-by":"publisher","first-page":"614448","DOI":"10.3389\/fonc.2021.614448","volume":"11","author":"P Sarkar","year":"2021","unstructured":"Sarkar, P. et al. Dysbiosis of oral microbiota during oral squamous cell carcinoma development. Front. Oncol. 11, 614448. https:\/\/doi.org\/10.3389\/fonc.2021.614448 (2021).","journal-title":"Front. Oncol."},{"key":"52247_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.21147\/j.issn.1000-9604.2020.06.07","volume":"32","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control study. Chin. J. Cancer Res. 32, 742\u2013754. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2020.06.07 (2020).","journal-title":"Chin. J. Cancer Res."},{"key":"52247_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fmicb.2018.00862","volume":"9","author":"CY Yang","year":"2018","unstructured":"Yang, C. Y. et al. Oral microbiota community dynamics associated with oral squamous cell carcinoma staging. Front. Microbiol. 9, 862. https:\/\/doi.org\/10.3389\/fmicb.2018.00862 (2018).","journal-title":"Front. Microbiol."},{"key":"52247_CR20","doi-asserted-by":"publisher","first-page":"2079814","DOI":"10.1080\/20002297.2022.2079814","volume":"14","author":"E Kononen","year":"2022","unstructured":"Kononen, E., Fteita, D., Gursoy, U. K. & Gursoy, M. Prevotella species as oral residents and infectious agents with potential impact on systemic conditions. J. Oral Microbiol. 14, 2079814. https:\/\/doi.org\/10.1080\/20002297.2022.2079814 (2022).","journal-title":"J. Oral Microbiol."},{"key":"52247_CR21","doi-asserted-by":"publisher","unstructured":"Moreira, C., Figueiredo, C. & Ferreira, R. M. The role of the microbiota in esophageal cancer. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/cancers15092576 (2023).","DOI":"10.3390\/cancers15092576"},{"key":"52247_CR22","doi-asserted-by":"publisher","first-page":"11773","DOI":"10.1038\/s41598-017-11779-9","volume":"7","author":"H Zhao","year":"2017","unstructured":"Zhao, H. et al. Variations in oral microbiota associated with oral cancer. Sci. Rep. 7, 11773. https:\/\/doi.org\/10.1038\/s41598-017-11779-9 (2017).","journal-title":"Sci. Rep."},{"key":"52247_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fcimb.2020.00268","volume":"10","author":"D Li","year":"2020","unstructured":"Li, D. et al. Characterization of the esophageal microbiota and prediction of the metabolic pathways involved in esophageal cancer. Front. Cell. Infect. Microbiol. 10, 268. https:\/\/doi.org\/10.3389\/fcimb.2020.00268 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"52247_CR24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12272-015-0549-z","volume":"38","author":"SM Jeon","year":"2015","unstructured":"Jeon, S. M. & Hay, N. The double-edged sword of AMPK signaling in cancer and its therapeutic implications. Arch. Pharm. Res. 38, 346\u2013357. https:\/\/doi.org\/10.1007\/s12272-015-0549-z (2015).","journal-title":"Arch. Pharm. Res."},{"key":"52247_CR25","doi-asserted-by":"publisher","first-page":"103375","DOI":"10.1016\/j.jtherbio.2022.103375","volume":"110","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Lysine promotes proliferation and \u03b2-casein synthesis through the SLC6A14-ERK1\/2-CDK1-mTOR signaling pathway in bovine primary mammary epithelial cells. J. Therm. Biol. 110, 103375 (2022).","journal-title":"J. Therm. Biol"},{"key":"52247_CR26","doi-asserted-by":"publisher","unstructured":"Wei, J., Hu, M., Huang, K., Lin, S. & Du, H. Roles of proteoglycans and glycosaminoglycans in cancer development and progression. Int. J. Mol. Sci. 21. https:\/\/doi.org\/10.3390\/ijms21175983 (2020).","DOI":"10.3390\/ijms21175983"},{"key":"52247_CR27","doi-asserted-by":"publisher","first-page":"38755","DOI":"10.18632\/oncotarget.16333","volume":"8","author":"B Li","year":"2017","unstructured":"Li, B. et al. Significance of PI3K\/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy. Oncotarget 8, 38755\u201338766 (2017).","journal-title":"Oncotarget"},{"key":"52247_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djw230","volume":"109","author":"S Mocellin","year":"2017","unstructured":"Mocellin, S., Briarava, M. & Pilati, P. Vitamin B6 and cancer risk: A field synopsis and meta-analysis. J. Natl. Cancer Inst. 109, 1\u20139. https:\/\/doi.org\/10.1093\/jnci\/djw230 (2017).","journal-title":"J. Natl. Cancer Inst."},{"key":"52247_CR29","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41467-021-23068-1","volume":"12","author":"MS Svetlov","year":"2021","unstructured":"Svetlov, M. S. et al. Context-specific action of macrolide antibiotics on the eukaryotic ribosome. Nat. Commun. 12, 2803. https:\/\/doi.org\/10.1038\/s41467-021-23068-1 (2021).","journal-title":"Nat. Commun."},{"key":"52247_CR30","doi-asserted-by":"publisher","unstructured":"Larsen, P. E. & Dai, Y. Metabolome of human gut microbiome is predictive of host dysbiosis. Gigascience 4. https:\/\/doi.org\/10.1186\/s13742-015-0084-3 (2015).","DOI":"10.1186\/s13742-015-0084-3"},{"key":"52247_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1183\/09031936.00042208","volume":"33","author":"PAJ Crosbie","year":"2009","unstructured":"Crosbie, P. A. J. & Woodhead, M. A. Long-term macrolide therapy in chronic inflammatory airway diseases. Eur. Respir J. 33, 171\u2013181. https:\/\/doi.org\/10.1183\/09031936.00042208 (2009).","journal-title":"Eur. Respir J."},{"key":"52247_CR32","doi-asserted-by":"publisher","first-page":"110072","DOI":"10.1016\/j.cbi.2022.110072","volume":"365","author":"R Das","year":"2022","unstructured":"Das, R. et al. Therapeutic potential of marine macrolides: An overview from 1990 to 2022. Chem. Biol. Interact. 365, 110072. https:\/\/doi.org\/10.1016\/j.cbi.2022.110072 (2022).","journal-title":"Chem. Biol. Interact."},{"key":"52247_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/1751-7915.13488","volume":"13","author":"P Pimviriyakul","year":"2020","unstructured":"Pimviriyakul, P., Wongnate, T., Tinikul, R. & Chaiyen, P. Microbial degradation of halogenated aromatics: Molecular mechanisms and enzymatic reactions. Microb. Biotechnol. 13, 67\u201386. https:\/\/doi.org\/10.1111\/1751-7915.13488 (2020).","journal-title":"Microb. Biotechnol."},{"key":"52247_CR34","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1128\/MMBR.00006-10","volume":"74","author":"KS Ju","year":"2010","unstructured":"Ju, K. S. & Parales, R. E. Nitroaromatic compounds, from synthesis to biodegradation. Microbiol. Mol. Biol. Rev. 74, 250\u2013272. https:\/\/doi.org\/10.1128\/MMBR.00006-10 (2010).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"52247_CR35","doi-asserted-by":"publisher","unstructured":"Andrei, C., Zanfirescu, A., Ormeneanu, V. P. & Negres, S. Evaluating the efficacy of secondary metabolites in antibiotic-induced dysbiosis: A narrative review of preclinical studies. Antibiotics (Basel) 14. https:\/\/doi.org\/10.3390\/antibiotics14020138 (2025).","DOI":"10.3390\/antibiotics14020138"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52247-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52247-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52247-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:02:12Z","timestamp":1783515732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52247-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52247"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52247-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Research Ethics Committee of NTUH affiliated with the National Taiwan University College of Medicine (IRB number 201805081RINC). Written informed consent was obtained from all participants. All procedures were performed in accordance with relevant guidelines and regulations and with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"21145"}}